Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma

NCT03466827 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Thymoma
Advanced Thymic Epithelial Tumour

Interventions

DRUG: Selinexor

Sponsor

Morten Mau-Soerensen

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]